IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 97 filers reported holding IMMUNOVANT INC in Q2 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,849,272 | +190.0% | 126,316 | +43.3% | 0.00% | +300.0% |
| Q2 2023 | $1,671,959 | -70.3% | 88,137 | -75.7% | 0.00% | -66.7% |
| Q1 2023 | $5,632,720 | +209.4% | 363,167 | +254.1% | 0.00% | +200.0% |
| Q4 2022 | $1,820,635 | +10609.6% | 102,571 | +3366.4% | 0.00% | – |
| Q3 2022 | $17,000 | -22.7% | 2,959 | -47.9% | 0.00% | – |
| Q2 2022 | $22,000 | -24.1% | 5,675 | +6.6% | 0.00% | – |
| Q1 2022 | $29,000 | -97.8% | 5,322 | -96.6% | 0.00% | -100.0% |
| Q4 2021 | $1,316,000 | -44.9% | 154,499 | -43.8% | 0.00% | 0.0% |
| Q3 2021 | $2,390,000 | -29.3% | 275,049 | -14.0% | 0.00% | -50.0% |
| Q2 2021 | $3,381,000 | -13.1% | 319,878 | +31.8% | 0.00% | -33.3% |
| Q1 2021 | $3,892,000 | +366.7% | 242,621 | +1243.3% | 0.00% | – |
| Q4 2020 | $834,000 | +983.1% | 18,062 | +722.9% | 0.00% | – |
| Q3 2020 | $77,000 | -75.8% | 2,195 | -83.2% | 0.00% | – |
| Q2 2020 | $318,000 | +1172.0% | 13,080 | +703.4% | 0.00% | – |
| Q1 2020 | $25,000 | – | 1,628 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |